We invite everyone to join an upcoming educational webinar that will focus on challenges, strategies, and resources for loved ones of cancer patients—particularly those affected by advanced or metastatic cancer. You Are Not Alone—Validating the Caregiver Experience, will be offered virtually on May 18, 2022, at 12:00 PM PT / 3:00 PM ET. Many who reach out to Cancer Commons for help are among… Read more »
We invite everyone to join a March 2 webinar featuring Cancer Commons Chief Scientist Emma Shtivelman, PhD, in conversation with Cancer Commons Editor in Chief George Lundberg, MD. They will discuss cutting-edge options and trends in breast cancer treatment. The conversation offers an opportunity for cancer patients, survivors, caregivers, and medical professionals to understand the latest significant advancements in treating metastatic breast cancer, engage… Read more »
A virtual tumor board program launched at Cancer Commons in 2020 has shown preliminary promise in helping pancreatic cancer patients identify and access treatments, clinical trials, and diagnostic opportunities tailored to each patient’s individual case. Our Director of Scientific and Clinical Affairs, Lola Rahib, PhD, led evaluation of the initial success of the program, which is presented today at the American Society of Clinical… Read more »
Cancer Commons Scientist Matthew Warner, PhD, is a self-described East London boy who, back home, speaks with his brothers in Cockney rhyming slang that few would understand. Here, to the brain cancer patients he serves, Matt is a source of deep knowledge, understanding, and support. Matt’s expertise stems from years of cancer research—beginning with his graduate training at the University of Cambridge and extending… Read more »
“You wouldn’t think that briefly bumping against the wall in your own house would signal a huge life change for you and your whole family. But that’s what happened to Leo Weisheit, a 63-year-old IT consultant in New Jersey.” Read the story of Leo and his wife Roxanne, who turned to Cancer Commons and our partner the Musella Foundation for help navigating Leo’s brain… Read more »
A new article published by Lets Win! Pancreatic Cancer highlights the invaluable role played by our Oncology Patient Navigator Deborah Christensen, M.S.N., A.P.R.N., A.O.C.N.S., A.G.C.N.S.-B.C., O.C.N. “When you receive a cancer diagnosis—pancreatic or any other type—what you really need is a skilled oncology nurse navigator to take your hand and guide you through the process.” Read the article to learn how Deb provides this essential service.
In the next two decades, U.S. rankings of the most common and deadly cancer types will shift, reflecting the influence of screening programs and advancements in treatment. Lola Rahib, PhD, Director of Scientific and Clinical Affairs at Cancer Commons, led this research, which appears today in JAMA Network Open. The projections were prepared in collaboration with the Pancreatic Cancer Action Network (PanCAN) and The… Read more »
Cancer Commons founder Marty Tenenbaum, PhD, will join other leading innovators and experts next week as a panelist at the 2021 virtual Precision Medicine World Conference (PMWC). This year’s theme is “21st Century Precision Medicine in the Age of COVID-19.” On Monday, Jan 25, at 1pm PST, Marty will engage with other distinguished panelists in an exploration of how to make clinical trials more accessible… Read more »
Despite 2020 creating some of the most difficult circumstances of our lifetimes, it was a year of progress for Cancer Commons. Cancer Commons’ Model Validated Cancer Commons helps patients and their physicians collectively explore the latest and best treatment options far more efficiently than they can as individuals, often via a “molecular tumor board” model that precisely matches patients to personalized options. We recently… Read more »
This month, Cancer Commons earned the 2020 Platinum Seal of Transparency from GuideStar, a database that helps the public evaluate the performance of all nonprofits in the U.S. The Platinum Seal of Transparency is the highest level of recognition offered by GuideStar. To reach the Platinum level, Cancer Commons added extensive information to our profile on GuideStar: basic contact and organizational information; in-depth financial… Read more »